PlainRecalls
FDA Drug Moderate Class II Terminated

Lisinopril Tablets, USP, 5 mg, Rx Only, 1000-count bottle, Manufactured for: Lupin Pharmaceuticals Inc., Baltimore, MD 21202, Manufactured by: Lupin Limited, Nagpur - 441 108, India, NDC 68180-513-03.

Reported: June 17, 2020 Initiated: May 28, 2020 #D-1290-2020

Product Description

Lisinopril Tablets, USP, 5 mg, Rx Only, 1000-count bottle, Manufactured for: Lupin Pharmaceuticals Inc., Baltimore, MD 21202, Manufactured by: Lupin Limited, Nagpur - 441 108, India, NDC 68180-513-03.

Reason for Recall

Product Mix Up: Lisinopril 10 mg tablets were found in Lisinopril 5 mg 1000-count bottle.

Details

Units Affected
4,224 bottles
Distribution
Nationwide within the US.
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Lisinopril Tablets, USP, 5 mg, Rx Only, 1000-count bottle, Manufactured for: Lupin Pharmaceuticals Inc., Baltimore, MD 21202, Manufactured by: Lupin Limited, Nagpur - 441 108, India, NDC 68180-513-03.. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 4,224 bottles.
Why was this product recalled?
Product Mix Up: Lisinopril 10 mg tablets were found in Lisinopril 5 mg 1000-count bottle.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 17, 2020. Severity: Moderate. Recall number: D-1290-2020.